Zuzana Kos

7.1k total citations
32 papers, 512 citations indexed

About

Zuzana Kos is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Zuzana Kos has authored 32 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 14 papers in Cancer Research and 7 papers in Molecular Biology. Recurrent topics in Zuzana Kos's work include Breast Cancer Treatment Studies (12 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cancer Genomics and Diagnostics (6 papers). Zuzana Kos is often cited by papers focused on Breast Cancer Treatment Studies (12 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cancer Genomics and Diagnostics (6 papers). Zuzana Kos collaborates with scholars based in Canada, United States and Denmark. Zuzana Kos's co-authors include Torsten O. Nielsen, Dongxia Gao, Samuel Leung, Shuzhen Liu, David J. Dabbs, William D. Foulkes, Sherman Lau, Phillip Williams, Samantha Burugu and Eric C. Bélanger and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Zuzana Kos

30 papers receiving 502 citations

Peers

Zuzana Kos
Jolanta Szelachowska Poland
Poh Yin Yew Japan
Marcella Marconi Italy
Paulina Lange United States
Abha Soni United States
Jessica Esandrio United States
Takaharu Hatano Japan
Yoshika Nagata Japan
I Ruschenburg Germany
Ehab Husain United Kingdom
Jolanta Szelachowska Poland
Zuzana Kos
Citations per year, relative to Zuzana Kos Zuzana Kos (= 1×) peers Jolanta Szelachowska

Countries citing papers authored by Zuzana Kos

Since Specialization
Citations

This map shows the geographic impact of Zuzana Kos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zuzana Kos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zuzana Kos more than expected).

Fields of papers citing papers by Zuzana Kos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zuzana Kos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zuzana Kos. The network helps show where Zuzana Kos may publish in the future.

Co-authorship network of co-authors of Zuzana Kos

This figure shows the co-authorship network connecting the top 25 collaborators of Zuzana Kos. A scholar is included among the top collaborators of Zuzana Kos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zuzana Kos. Zuzana Kos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alikhassi, Afsaneh, Anita Bane, Erin Cordeiro, et al.. (2025). Canadian Recommendations on Optimal Breast Biopsy Practices Developed Using a Modified Delphi Panel. Canadian Association of Radiologists Journal. 76(4). 705–719. 1 indexed citations
2.
Riaz, Nazia, Bingshu E. Chen, Anita Bane, et al.. (2025). Prognostic and predictive capacity of tumor infiltrating lymphocytes in the MA.20 regional node radiotherapy trial. npj Breast Cancer. 11(1). 97–97.
3.
He, Ye, et al.. (2025). Digital Profiling of Immune Biomarkers in Breast Cancer: Relation to Anthracycline Benefit. Modern Pathology. 38(5). 100718–100718. 1 indexed citations
4.
Nielsen, Torsten O., Samuel Leung, Nazia Riaz, et al.. (2023). Ki67 assessment protocol as an integral biomarker for avoiding radiotherapy in the LUMINA breast cancer trial. Histopathology. 83(6). 903–911. 3 indexed citations
5.
Faragalla, Hala, Anna Plotkin, Penny J. Barnes, et al.. (2023). Ki67 in Breast Cancer Assay: An Ad Hoc Testing Recommendation from the Canadian Association of Pathologists Task Force. Current Oncology. 30(3). 3079–3090. 6 indexed citations
6.
Leung, Samuel, et al.. (2023). Abstract P6-04-02: Ki67 Assessment Protocol: Companion Diagnostic Biomarker for LUMINA Prospective Cohort Study. Cancer Research. 83(5_Supplement). P6–4. 1 indexed citations
7.
Kos, Zuzana, Torsten O. Nielsen, & Anne‐Vibeke Lænkholm. (2023). Breast Cancer Histopathology in the Age of Molecular Oncology. Cold Spring Harbor Perspectives in Medicine. 14(6). a041647–a041647. 5 indexed citations
8.
Riaz, Nazia, et al.. (2021). SRY‐box transcription factor 10 is a highly specific biomarker of basal‐like breast cancer. Histopathology. 80(3). 589–597. 7 indexed citations
9.
Burugu, Samantha, Dongxia Gao, Zuzana Kos, et al.. (2020). Evaluation of glucocorticoid-induced TNF receptor (GITR) expression in breast cancer and across multiple tumor types. Modern Pathology. 33(9). 1753–1763. 21 indexed citations
10.
Slodkowska, Elzbieta, Bin Xu, Zuzana Kos, et al.. (2019). Predictors of Outcome in Mammary Adenoid Cystic Carcinoma. The American Journal of Surgical Pathology. 44(2). 214–223. 30 indexed citations
11.
Robertson, Susan J., Gregory R. Pond, John Hilton, et al.. (2019). Selecting Patients for Oncotype DX Testing Using Standard Clinicopathologic Information. Clinical Breast Cancer. 20(1). 61–67. 7 indexed citations
12.
Howitt, Brooke E., John K. Schoolmeester, Lauren E. Schwartz, et al.. (2017). Architectural overlap between benign endocervix and pattern-A endocervical adenocarcinoma: Are all pattern-A tumors invasive?. Pathology - Research and Practice. 213(7). 799–803. 10 indexed citations
13.
He, Yi, Jason J. Northey, Andrea Pelletier, et al.. (2017). The Cdc42/Rac1 regulator CdGAP is a novel E-cadherin transcriptional co-repressor with Zeb2 in breast cancer. Oncogene. 36(24). 3490–3503. 34 indexed citations
14.
Sheffield, Brandon S., Zuzana Kos, Karama Asleh, et al.. (2016). Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptor. Breast Cancer Research and Treatment. 155(3). 483–490. 27 indexed citations
15.
Asleh, Karama, Brandon S. Sheffield, Zuzana Kos, et al.. (2016). Basal biomarkers nestin and INPP4b identify intrinsic subtypes accurately in breast cancers that are weakly positive for oestrogen receptor. Histopathology. 70(2). 185–194. 14 indexed citations
16.
Kos, Zuzana & David J. Dabbs. (2015). Biomarker assessment and molecular testing for prognostication in breast cancer. Histopathology. 68(1). 70–85. 51 indexed citations
17.
18.
Kos, Zuzana, Russell R. Broaddus, & Bojana Djordjevic. (2014). Fallopian Tube High-grade Serous Carcinoma With Intramucosal Spread and Presenting as a Malignancy on Pap Smear. International Journal of Gynecological Pathology. 33(4). 443–448. 6 indexed citations
19.
Kos, Zuzana, Susan J. Robertson, Bibianna Purgina, Shailendra Verma, & Denis Gravel. (2013). Malignant peripheral nerve sheath tumor arising in a traumatic neuroma: a case report. Human Pathology. 44(10). 2360–2364. 7 indexed citations
20.
Kien, T., Trevor A. Flood, Phillip Williams, Zuzana Kos, & Eric C. Bélanger. (2013). Mixed low- and high-grade papillary urothelial carcinoma: histopathogenetic and clinical significance. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 463(4). 575–581. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jolanta Szelachowska Breakdown of academic impact, for papers by Poh Yin Yew Breakdown of academic impact, for papers by Marcella Marconi Breakdown of academic impact, for papers by Paulina Lange Breakdown of academic impact, for papers by Abha Soni Breakdown of academic impact, for papers by Jessica Esandrio Breakdown of academic impact, for papers by Takaharu Hatano Breakdown of academic impact, for papers by Yoshika Nagata Breakdown of academic impact, for papers by I Ruschenburg Breakdown of academic impact, for papers by Ehab Husain
Rankless by CCL
2026